Similar articles

• Optimal results in cadaver-donor renal transplantation using prophylactic ALG, cyclosporine, and prednisone.

  Hiesse C, Fries D, Charpentier B, Neyrat N, Rieu P, Cantarovich M, Lantz O, Bellamy J, Benoit G. Hiesse C, et al. Transplant Proc. 1987 Oct;19(5):3670-1. Transplant Proc. 1987. PMID: 3313885 No abstract available.
• Low incidence of rejection and in vitro donor-specific hyporesponsiveness using pretransplant ALG, low-dose cyclosporine, and steroids in kidney cadaveric transplantation.

  Griñó JM, Bas J, Gonzalez C, Castelao AM, Seron D, Mestre M, Buendia E, Sabate R, Diaz C, Alsina J. Griñó JM, et al. Transplant Proc. 1990 Aug;22(4):1367-8. Transplant Proc. 1990. PMID: 2143855 No abstract available.
• Low-dose cyclosporine, anti-lymphocyte globulin, and steroids in first cadaveric renal transplantation.

  Griño JM, Alsina J, Castelao AM, Sabate I, Mestre M, Gil-Vernet S, Andrés E, Sabater R. Griño JM, et al. Transplant Proc. 1988 Oct;20(5 Suppl 6):18-20. Transplant Proc. 1988. PMID: 3051579 Clinical Trial. No abstract available.
• Is withdrawal of steroids hazardous to cadaveric renal transplants under treatment with cyclosporine?

  Hillebrand G, Krumme D, Schleibner S, Land W, Gurland HJ. Hillebrand G, et al. Transplant Proc. 1988 Jun;20(3 Suppl 3):126-9. Transplant Proc. 1988. PMID: 3291225 No abstract available.
• Steps in immunosuppression for renal transplantation.

  Starzl TE, Rosenthal JT, Hakala TR, Iwatsuki S, Shaw BW Jr, Klintmalm GB. Starzl TE, et al. Kidney Int Suppl. 1983 May;(14):S-60-5. Kidney Int Suppl. 1983. PMID: 6348374 Free PMC article. Review. No abstract available.